Jun Ma
44Patents
8h-index
57Co-inventors
74Inventor score
Filing activity: Jun 8, 2009 → Aug 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9085599B2 | 2′allene-substituted nucleoside derivatives | Human Necessities | 36 | Active |
| US10034893B2 | 5, 6-D2 uridine nucleoside/tide derivatives | Chemistry; Metallurgy | 33 | Active |
| US8846638B2 | Macrocyclic nucleoside phosphoramidate derivatives | Chemistry; Metallurgy | 23 | Active |
| US11384090B2 | Spiropyrrolidine derived antiviral agents | Chemistry; Metallurgy | 10 | Active |
| US10450301B2 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US10246439B2 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US9169141B2 | Water treatment method by catalyzing ozone with a persulfate | Chemistry; Metallurgy | 8 | Active |
| US10683279B2 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US10253018B2 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US9220748B2 | Macrocyclic proline derived HCV serine protease inhibitors | Human Necessities | 5 | Active |
| US10450306B2 | Isoxazole analogs as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US8648037B2 | Macrocyclic proline derived HCV serine protease inhibitors | Human Necessities | 4 | Active |
| US10080743B2 | Isoxazole derivatives as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10080741B2 | Isoxazole derivatives as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10988458B2 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10080742B2 | Isoxazole derivatives as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10689391B2 | Isoxazole analogs as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11560368B2 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10149835B2 | Isoxazole derivatives as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10144729B2 | Isoxazole analogs as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10597391B2 | Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof | Human Necessities | 1 | Active |
| US10829486B2 | Isoxazole derivatives as FXR agonists and methods of use thereof | Human Necessities | 1 | Active |
| US8858827B2 | Water treatment agent for removing pollutant by reinforcing potassium permanganate with intermediate manganes | Chemistry; Metallurgy | 1 | Active |
| US11034684B2 | Isoxazole analogs as FXR agonists and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US10138228B2 | Isoxazole derivatives as FXR agonists and methods of use therof | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.